Literature DB >> 14617357

Recombinant antibodies against subcellular fractions used to track endogenous Golgi protein dynamics in vivo.

Clément Nizak1, Silvia Martin-Lluesma, Sandrine Moutel, Aurélien Roux, Thomas E Kreis, Bruno Goud, Franck Perez.   

Abstract

Generation of specific antibodies against enriched subcellular fractions is a powerful strategy to identify and characterize cellular components. We show that recombinant antibodies can be selected in vitro by phage display against complex subcellular fractions, namely microtubule-binding proteins and Golgi stacks. This technique has allowed us to overcome many limitations of the classical animal-based approach and generate cell biology-compliant antibodies. In addition, we show that intracellular expression of GFP-tagged recombinant antibodies can reveal the dynamics of endogenous proteins in vivo. Endogenous Giantin is very static and outlines the Golgi in living cells. It accumulates neither onto Golgi-derived tubules upon Brefeldin A treatment before Golgi disappearance, nor onto de novo formed Golgi mini-stacks upon microtubule depolymerization, and remains instead on the 'old' pericentriolar Golgi. This suggests that, in contrast to other Golgi matrix proteins, endogenous Giantin is very stably associated with the Golgi and does not efficiently recycle to the ER. Altogether, we show that the antibody phage display technique represents an efficient alternative to rapidly generate versatile antibodies that represent new tools to study protein function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14617357     DOI: 10.1034/j.1600-0854.2003.00132.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  40 in total

1.  The entire Nup107-160 complex, including three new members, is targeted as one entity to kinetochores in mitosis.

Authors:  Isabelle Loïodice; Annabelle Alves; Gwénaël Rabut; Megan Van Overbeek; Jan Ellenberg; Jean-Baptiste Sibarita; Valérie Doye
Journal:  Mol Biol Cell       Date:  2004-05-14       Impact factor: 4.138

2.  IBC's 22nd Annual Antibody Engineering and 9th Annual Antibody Therapeutics International Conferences and the 2011 Annual Meeting of The Antibody Society, December 5-8, 2011, San Diego, CA.

Authors:  Johan Nilvebrant; D Cameron Dunlop; Aroop Sircar; Thierry Wurch; Emilia Falkowska; Janice M Reichert; Gustavo Helguera; Emily C Piccione; Simon Brack; Sven Berger
Journal:  MAbs       Date:  2012-03-01       Impact factor: 5.857

3.  A role for the Rab6A' GTPase in the inactivation of the Mad2-spindle checkpoint.

Authors:  Stéphanie Miserey-Lenkei; Anne Couëdel-Courteille; Elaine Del Nery; Sabine Bardin; Matthieu Piel; Victor Racine; Jean-Baptiste Sibarita; Franck Perez; Michel Bornens; Bruno Goud
Journal:  EMBO J       Date:  2006-01-05       Impact factor: 11.598

4.  Analysis of de novo Golgi complex formation after enzyme-based inactivation.

Authors:  Florence Jollivet; Graça Raposo; Ariane Dimitrov; Rachid Sougrat; Bruno Goud; Franck Perez
Journal:  Mol Biol Cell       Date:  2007-09-12       Impact factor: 4.138

5.  Direct selection of monoclonal phosphospecific antibodies without prior phosphoamino acid mapping.

Authors:  Ole Vielemeyer; Hebao Yuan; Sandrine Moutel; Rénette Saint-Fort; Danming Tang; Clément Nizak; Bruno Goud; Yanzhuang Wang; Franck Perez
Journal:  J Biol Chem       Date:  2009-05-27       Impact factor: 5.157

Review 6.  The many routes of Golgi-dependent trafficking.

Authors:  Gaelle Boncompain; Franck Perez
Journal:  Histochem Cell Biol       Date:  2013-07-12       Impact factor: 4.304

7.  A soft cortex is essential for asymmetric spindle positioning in mouse oocytes.

Authors:  Agathe Chaigne; Clément Campillo; Nir S Gov; Raphaël Voituriez; Jessica Azoury; Claudia Umaña-Diaz; Maria Almonacid; Isabelle Queguiner; Pierre Nassoy; Cécile Sykes; Marie-Hélène Verlhac; Marie-Emilie Terret
Journal:  Nat Cell Biol       Date:  2013-07-14       Impact factor: 28.824

8.  Live imaging of endogenous PSD-95 using ENABLED: a conditional strategy to fluorescently label endogenous proteins.

Authors:  Dale A Fortin; Shane E Tillo; Guang Yang; Jong-Cheol Rah; Joshua B Melander; Suxia Bai; Omar Soler-Cedeño; Maozhen Qin; Boris V Zemelman; Caiying Guo; Tianyi Mao; Haining Zhong
Journal:  J Neurosci       Date:  2014-12-10       Impact factor: 6.167

9.  8p22 MTUS1 gene product ATIP3 is a novel anti-mitotic protein underexpressed in invasive breast carcinoma of poor prognosis.

Authors:  Sylvie Rodrigues-Ferreira; Anne Di Tommaso; Ariane Dimitrov; Sylvie Cazaubon; Nadège Gruel; Hélène Colasson; André Nicolas; Nathalie Chaverot; Vincent Molinié; Fabien Reyal; Brigitte Sigal-Zafrani; Benoit Terris; Olivier Delattre; François Radvanyi; Franck Perez; Anne Vincent-Salomon; Clara Nahmias
Journal:  PLoS One       Date:  2009-10-01       Impact factor: 3.240

10.  A multi-Fc-species system for recombinant antibody production.

Authors:  Sandrine Moutel; Ahmed El Marjou; Ole Vielemeyer; Clément Nizak; Philippe Benaroch; Stefan Dübel; Franck Perez
Journal:  BMC Biotechnol       Date:  2009-02-26       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.